Home News The first laboratory results on Omicron: “Net decrease in the effectiveness of antibodies, but the third dose brings them back to the top”

The first laboratory results on Omicron: “Net decrease in the effectiveness of antibodies, but the third dose brings them back to the top”

by admin

The first laboratory results on the Omicron variant arrive from South Africa. The loss of efficacy of the Pfizer vaccine is “substantial, if not complete,” writes the group of scientists led by Alex Sigal, of the Africa Health Research Institute, in a study published so far in MedrXiv. And the pharmaceutical company announces: “The new vaccine is expected in March”.

.

0 comment
0

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy